Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts

Generated: July 21, 2019

DrugPatentWatch Database Preview

Patent: 7,368,438

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,368,438
Title:Non-nucleotide compositions and method for inhibiting platelet aggregation
Abstract: This invention is directed to a method of preventing or treating diseases or conditions associated with platelet aggregation. The method is also directed to a method of treating thrombosis or related disorders. The method comprises administering to a subject a pharmaceutical composition comprising an effective amount of a non-nucleotide compound, preferably a P2Y.sub.12 receptor antagonist compound, wherein said amount is effective to inhibit platelet aggregation. The compounds useful for this invention include compounds of general Formula I and III-XI, or salts, hydrates, and solvates thereof. The present invention also provides novel compounds according to Formula I and III-XI.
Inventor(s): Plourde, Jr.; Robert (Chapel Hill, NC), Shaver; Sammy R. (Chapel Hill, NC), Boyer; Jose L. (Chapel Hill, NC), Abreo; Melwyn A. (Jamul, CA), Alfaro-Lopez; Lorenzo J. (San Marcos, CA), Feng; Yangbo (Palm Beach Gardens, FL), Harvey; Daniel F. (San Diego, CA), Khasonova; Tatyana V. (San Diego, CA), Tu; Chi (San Diego, CA)
Assignee: Inspire Pharmaceuticals, Inc. (Durham, NC)
Application Number:10/971,766
Patent Claims:see list of patent claims

Details for Patent 7,368,438

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Centocor Inc REOPRO abciximab INJECTABLE; INJECTION 103575 001 1994-12-22 ➤ Sign Up Inspire Pharmaceuticals, Inc. (Durham, NC) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 7,368,438

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.